Mathews Journal of Pharmaceutical Science (MJPS; ISSN: 2474-753X) is international scholarly journal that publishes original research pertaining to diverse pharmaceutical science related topics, such as pro-drug development, drug delivery, drug action, clinical research, drug stability, dosage form design, rational use of pharmacotherapy, metabolic disposition of bioactive agents, targeted drug delivery, regulatory affairs, pharmaceutical biotechnology, pharmacokinetics, pharmacodynamics, ADME, pharmaceutical analysis, bioequivalence and bioavailability, molecular pharmaceutics, biopharmaceutics, microencapsulation, and protein-peptide chemistry with specific focus on pharmaceutical technology.
Special impetus is placed on papers related to drug safety and dealing with topics, such as pharmacoepidemiology, pharmacovigilance, risk management, benefit-risk assessment, and medication error prevention.
This leading journal on the field of Pharmacy and Pharmacology publishes critical reviews, perspectives, commentaries, and original research articles at the interface of disciplines itemized within pharmaceutical and related sciences, and takes great pride in keeping pace with latest research on how drug action/activity may be optimized using new technologies.
Why publish with us?
High Visibility: MJPS follows open access policy, thereby allowing the published articles to be accesses around the globe.
Promotion in Social Media: MJPS believes that serving the authors includes aggressively promoting their articles on social media platforms, and thereby ensuring them higher visibility.
Rigorous peer review: Every manuscript submitted undergoes a thorough and rigorous double-blind peer-review. This process eliminates subjective judgments and bias from the decision making process.
We welcome all types of articles related to Pharmaceutical Science. For submission assistance contact: i[email protected]. Please follow the Author Guidelines.
If you are not sure whether your work is suitable for this journal, please email us at i[email protected] or call us at +1-606-405–6566.
Published : 24th March 2025
Authors : Ferruccio Trifirò1,*, Paolo Zanirato2,#
Citation : Trifirò F, et al. (2025). Catalytic Options for Pharmaceuticals from CPhI Some Solutions to Problems. Mathews J Pharma Sci. 9(2):47.
Published : 12th March 2025
Authors : K Ravi Kumar*, B Ravindra Babu, Rashmi Rani Das
Citation : Ravi Kumar K, et al. (2025). Development and Optimization of Mesembrine Nanoliposome. Mathews J Pharma Sci. 9(2):46.
Published : 28th February 2025
Author : Didier Meyer*
Citation : Meyer D. (2025). Individual Stringent Mini Isolators for Autologous Cell Therapy. Mathews J Pharma Sci. 9(1):45.
Published : 28th February 2025
Authors : B Ravindra Babu*, Lagishetty Rishmitha
Citation : Ravindra Babu B, et al. (2025). Study of Solubility and Dissolution Rate of Stavudine Nanosuspension: Effect of Sonification Time. Mathews J Pharma Sci. 9(2):47.
Published : 20th February 2025
Authors : Ezegbe Chekwube Andrew1,3,*, Anikwe Chidera Celestine4, Ezegbe Amarachi Grace2,#, Okafor Nnedimma Pauline1, Odo Kenechi Benjamin1, Onyia Oluebube Chisom1, Agu-kalu Amarachi1, Ugorji Anita Chidera1, Uchenna Chiamaka Precious1, Onoduagu Simeon Chinedu1, Dingwoke Juliet Obianuju1, Onyekwere Favour Ezinne1
Citation : Andrew EC, et al. (2025). Mucoadhesive Polymer-Based Formulations for Drug Delivery. Mathews J Pharma Sci. 9(1):44.
Published : 31st January 2025
Authors : Ferruccio Trifirò1,*, Paolo Zanirato2,#
Citation : Trifirò, et al. (2025). Recent ECHA and POP Restrictions On the Use of Substances from the PFAS Family. Mathews J Pharma Sci. 9(1):42.